Impact of Genetic Polymorphisms of SLC2A2, SLC2A5, and KHK on Metabolic Phenotypes in Hypertensive Individuals

• MyPhuong T. Le,

  Affiliation Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida, United States of America

  ⨯
• Maximilian T. Lobmeyer,

  Affiliation Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida, United States of America

  ⨯
• Marcus Campbell,

  Affiliation Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida, United States of America

  ⨯
• Jing Cheng,

  Affiliation Department of Epidemiology and Health Policy Research, College of Medicine, University of Florida, Gainesville, Florida, United States of America

  ⨯
• Zhiying Wang,

  Affiliation Human Genetics Center and Institute of Molecular Medicine, University of Texas Health Science Center, Houston, Texas, United States of America

  ⨯
• Stephen T. Turner,

  Affiliation Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Arlene B. Chapman,

  Affiliation Renal Division, Department of Medicine, Emory University, Atlanta, Georgia, United States of America

  ⨯
• Eric Boerwinkle,

  Affiliation Human Genetics Center and Institute of Molecular Medicine, University of Texas Health Science Center, Houston, Texas, United States of America

  ⨯
• John G. Gums,

  Affiliation Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida, United States of America

  ⨯
• Yan Gong,

  Affiliation Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida, United States of America

  ⨯
• Richard J. Johnson,

  Affiliation Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Denver, Aurora, Colorado, United States of America

  ⨯
• Julie A. Johnson

  * E-mail: johnson@cop.ufl.edu

  Affiliation Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida, United States of America

  ⨯